![A randomized comparative trial of two low-dose oral isotretinoin regimens in moderate to severe acne vulgaris. - Abstract - Europe PMC A randomized comparative trial of two low-dose oral isotretinoin regimens in moderate to severe acne vulgaris. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5038098/bin/IDOJ-7-378-g005.jpg)
A randomized comparative trial of two low-dose oral isotretinoin regimens in moderate to severe acne vulgaris. - Abstract - Europe PMC
![An Open-label, Phase IV Study Evaluating Lidose-isotretinoin Administered without Food in Patients with Severe Recalcitrant Nodular Acne: Low Relapse Rates Observed Over the 104-week Post-treatment Period – JCAD | The Journal of An Open-label, Phase IV Study Evaluating Lidose-isotretinoin Administered without Food in Patients with Severe Recalcitrant Nodular Acne: Low Relapse Rates Observed Over the 104-week Post-treatment Period – JCAD | The Journal of](https://jcadonline.com/wp-content/uploads/DelRossoNov2019Table2.gif)
An Open-label, Phase IV Study Evaluating Lidose-isotretinoin Administered without Food in Patients with Severe Recalcitrant Nodular Acne: Low Relapse Rates Observed Over the 104-week Post-treatment Period – JCAD | The Journal of
![Acne clearance by number of courses of isotretinoin in patients treated... | Download Scientific Diagram Acne clearance by number of courses of isotretinoin in patients treated... | Download Scientific Diagram](https://www.researchgate.net/profile/Marius-Rademaker/publication/282913041/figure/tbl5/AS:895191053508610@1590441587529/Acne-clearance-by-number-of-courses-of-isotretinoin-in-patients-treated-for-acne-vulgaris_Q320.jpg)
Acne clearance by number of courses of isotretinoin in patients treated... | Download Scientific Diagram
![Prescribing isotretinoin for patients with acne in primary care - Best Practice Advocacy Centre New Zealand Prescribing isotretinoin for patients with acne in primary care - Best Practice Advocacy Centre New Zealand](https://bpac.org.nz/2017/img/isochart.jpg)
Prescribing isotretinoin for patients with acne in primary care - Best Practice Advocacy Centre New Zealand
![Patient demographics, dose, daily dose/kg, duration of treatment and... | Download Scientific Diagram Patient demographics, dose, daily dose/kg, duration of treatment and... | Download Scientific Diagram](https://www.researchgate.net/profile/Marius-Rademaker/publication/282913041/figure/tbl2/AS:895191053512704@1590441587443/Patient-demographics-dose-daily-dose-kg-duration-of-treatment-and-cumulative-dose-in_Q320.jpg)
Patient demographics, dose, daily dose/kg, duration of treatment and... | Download Scientific Diagram
![Acne relapse rate and predictors of relapse following treatment with oral isotretinoin. | Semantic Scholar Acne relapse rate and predictors of relapse following treatment with oral isotretinoin. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b1ae13cbff808f611e6893de6e4ef91c5495bce0/4-Table4-1.png)
Acne relapse rate and predictors of relapse following treatment with oral isotretinoin. | Semantic Scholar
![Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial - Indian Journal of Dermatology, Venereology and Leprology Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial - Indian Journal of Dermatology, Venereology and Leprology](https://ijdvl.com/content/126/2011/77/6/Images/ijdvl_2011_77_6_688_86482_t5.jpg)
Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial - Indian Journal of Dermatology, Venereology and Leprology
![Pharmaceutics | Free Full-Text | Self-Nanoemulsion Loaded with a Combination of Isotretinoin, an Anti-Acne Drug, and Quercetin: Preparation, Optimization, and In Vivo Assessment Pharmaceutics | Free Full-Text | Self-Nanoemulsion Loaded with a Combination of Isotretinoin, an Anti-Acne Drug, and Quercetin: Preparation, Optimization, and In Vivo Assessment](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-13-00046/article_deploy/html/images/pharmaceutics-13-00046-g006.png?1609555554)
Pharmaceutics | Free Full-Text | Self-Nanoemulsion Loaded with a Combination of Isotretinoin, an Anti-Acne Drug, and Quercetin: Preparation, Optimization, and In Vivo Assessment
![Frontiers | Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data Frontiers | Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data](https://www.frontiersin.org/files/Articles/733526/fphar-12-733526-HTML/image_m/fphar-12-733526-t001.jpg)
Frontiers | Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data
![Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial - Indian Journal of Dermatology, Venereology and Leprology Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial - Indian Journal of Dermatology, Venereology and Leprology](https://ijdvl.com/content/126/2011/77/6/Images/ijdvl_2011_77_6_688_86482_t3.jpg)
Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial - Indian Journal of Dermatology, Venereology and Leprology
![Analyzing the Efficacy of Isotretinoin in Treating Dissecting Cellulitis: A Literature Review and Meta-Analysis | SpringerLink Analyzing the Efficacy of Isotretinoin in Treating Dissecting Cellulitis: A Literature Review and Meta-Analysis | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40268-020-00335-y/MediaObjects/40268_2020_335_Fig2_HTML.png)
Analyzing the Efficacy of Isotretinoin in Treating Dissecting Cellulitis: A Literature Review and Meta-Analysis | SpringerLink
![Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review - JAAD International Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review - JAAD International](https://www.jaadinternational.org/cms/asset/8cbcafa3-00cb-4b53-8125-9c27b037ce9f/gr1.jpg)